Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study

NCT06304168 · clinicaltrials.gov ↗

RECRUITING

Status

6150

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm

Interventions

OTHER: Non-Interventional Study

Sponsor

Mayo Clinic